Location History:
- Milan, IT (2014)
- Rho, IT (2016)
Company Filing History:
Years Active: 2014-2016
Title: Tiziano Oldoni: Innovator in Pharmaceutical Treatments
Introduction
Tiziano Oldoni is a notable inventor based in Rho, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of myeloproliferative syndromes and the formulation of stable drug suspensions. With a total of 2 patents to his name, Oldoni's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
Oldoni's latest patents include groundbreaking methods for treating Philadelphia-negative myeloproliferative syndromes. His first patent details the use of histone deacetylase inhibitors, specifically administering diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride, or other pharmaceutically acceptable salts and/or solvates, in daily dosages ranging from 10 to 150 mg per patient. This method aims to provide effective care for patients suffering from these syndromes.
His second patent focuses on the development of physically and chemically stable aqueous oral suspensions of riluzole. These suspensions contain riluzole in particle form, along with a wetting agent, preferably a surfactant. The formulation ensures that riluzole is present in amounts from about 0.1% to about 20% w/v, with an average particle size lower than 200 µm. Notably, these suspensions are devoid of the known local anaesthetic effects of riluzole, enhancing their usability.
Career Highlights
Tiziano Oldoni has established himself as a key figure in pharmaceutical innovation. His work at Italfarmaco Spa has allowed him to explore and develop new treatment methodologies that address significant health issues. His dedication to research and development has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Oldoni collaborates with esteemed colleagues such as Paolo Mascagni and Roberta Artico. Their combined expertise fosters an environment of innovation and progress within their projects.
Conclusion
Tiziano Oldoni's contributions to pharmaceutical inventions demonstrate his commitment to improving patient care through innovative treatments. His patents reflect a deep understanding of complex medical needs and a drive to develop effective solutions.